DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Vision Care Market: North America Industry Analysis and Opportunity Assessment, 2016-2026” report to their offering. North America vision care market is projected to regis…
Category: News
New ‘Sectors Method’ Effective for Identifying Diabetic Retinopathy (CME/CE)
(MedPage Today) — Appeared to be good substitute for OCT
Researchers find children with ‘wobbly eye’ unable to recognise faces
Researchers in Southampton have discovered children who suffer from eye movement disorder nystagmus – known as ‘wobbly eye’ – struggle to recognise faces but not other objects.
Preeclampsia History Tied to Retinal Disorders
The most common disorders, occurring at least twice as often among women with a history of preeclampsia, included traction detachments, retinal breaks, and diabetic retinopathy. Medscape Medical News
Interview with Perry van Rijsingen, CEO of Preceyes Robotic Surgical Firm
Medgadget recently reported on the first successful use in patients of the Preceyes system for robotic vitroretinal surgery from Preceyes, a firm from Eindhoven, The Netherlands. We had the opportunity to ask Perry van Rijsingen, CEO of Preceyes some questions about the new technology and how the Preceyes team overcame some of the challenges m (Read more...)
TSRI scientists reveal how vision-loss treatment may leave the eyes, kidneys vulnerable to cellular damage
A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).
SageGlass Announces Completion of Dynamic Glass Installation at Bellavista Eye Clinic in Switzerland
MINNEAPOLIS–(BUSINESS WIRE)–SageGlass®, the pioneer of the world’s smartest electrochromic glass, installed dynamic glass on the floor-to-ceiling façade of the new 263,715-square-foot Bellavista Eye Clinic in Speicher, Switzerland. SageGlass, a product of Saint-Gobain, was chosen for its ability to provide access to natural daylight, which has been proven to be a major contributing factor to the patient recovery process. Extensive research has shown how light affects a patient’s wellbeing and
TSRI scientists find mechanism behind side effects in vision-loss treatment
A common class of drugs for vision loss may actually add to the problem in some patients, according to new research co-led by scientists at The Scripps Research Institute (TSRI).
Mount Sinai introduces first-ever Coursera course on HPV-associated oral and throat cancer
Mount Sinai’s Departments of Academic Informatics and Technology and Otolaryngology – Head and Neck Surgery, in conjunction with the Office of Continuing Medical Education at the Icahn School of Medicine at Mount Sinai, have launched the first-ever Cou…
Listing of Kubota Pharmaceutical Holdings Co., Ltd. and Forecast for Fiscal Year End 2016
TOKYO–(BUSINESS WIRE)–Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo: 4596) (the “Company”) hereby gives notice that the merger agreement regarding its proposed redomicile transaction became effective on December 1, 2016 Japan Time. On December 6, 2016 Japan Time, the Company has been listed on the Mothers market of the Tokyo Stock Exchange, Inc. (“TSE”). The Company has also announced earnings and dividend forecasts for the fiscal year end 2016 as follows. 1. Overview of Kubota Pharmaceutic
Increased UVB exposure associated with reduced risk of nearsightedness, particularly in teens, young
Higher ultraviolet B (UVB) radiation exposure, directly related to time outdoors and sunlight exposure, was associated with reduced odds of myopia (nearsightedness), and exposure to UVB between…
New drug treatment can override genetic fault that causes choroideremia
Researchers with funding from Fight for Sight have demonstrated that a new drug treatment for cystic fibrosis and Duchenne muscular dystrophy can override a genetic fault that causes choroideremia – a severe blinding disorder.
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) — This week’s topics include frailty and postoperative risk, smoking, age and myocardial infarction, sports and cardiovascular mortality, and artificial intelligence and diabetic retinopathy.
Increased UVB Exposure in Youth Reduces Adult Myopia Risk (CME/CE)
(MedPage Today) — No direct role for vitamin D, but high plasma lutein cuts odds by about 40%
Visual Recovery After Retinal Detachment With Macula-Off
Is there an optimal time point for the surgical repair of macula-off retinal detachment? The British Journal of Ophthalmology
Current Screening for Congenital CMV: Who Are We Missing?
The majority of infants born with congenital CMV infection are asymptomatic and thus missed with current screening strategies. What are the pros and cons of universal screening? CHOP Expert Commentary
Perceived Barriers to Diabetic Retinopathy Screening
Why aren’t many low income and minority diabetic patients being screened for diabetic retinopathy? This study found a striking divergence of opinion between patients and providers. Preventing Chronic Disease
MSHS introduces DigniCap scalp cooling system to reduce chemotherapy-induced hair loss
The Mount Sinai Health System announced the launch of the DigniCap scalp cooling system, which was recently cleared by the U.S. Food and Drug Administration to reduce the likelihood of chemotherapy-induced hair loss in women with breast cancer, in thre…
Eye surgery of the future: Gentle, efficient, out-patient surgery
The eye surgery of the future will be performed on an out-patient basis, will be gentle and efficient.
MSBI surgeons perform first endoscopic transoral thyroidectomy in New York
A team of surgeons at Mount Sinai Beth Israel, led by William B. Inabnet III, MD, the Eugene W. Friedman, MD, Professor of Surgery and Chair for the Department of Surgery at MSBI and Chief of Endocrine Surgery Quality for the Mount Sinai Health System,…